Home·Supplements·Mitocondria·Alpha-lipoic acid
II.·ii. Mitochondria · 7 of 8

Alpha-lipoic acid the universal mitochondrial antioxidant

Mandatory cofactor of PDH/KGDH (gateway to Krebs cycle) · only amphipathic antioxidant (lipo + hydrosoluble · crosses BBB) · recycles GSH, Vit C, Vit E, CoQ10. Ziegler SYDNEY: 600 mg/d × 6 months improves diabetic neuropathy. R-ALA is the real active form.

Robust neuropathy evidence300–600 mgR-ALA/dayFastingoptimal absorption~25 €/monthpure R-ALA
6Alpha-lipoic acid appears in 6 protocols personalizable
Optimal dose
300-600 mg
R-ALA · fasted morning
Best form
Stabilized R-ALA
not racemic R/S
Hallmarks
Mito · Redox
PDH/KGDH + recycles antiox
Top synergy
+ ALCAR (Ames combo)
young again mito
i.

What is alpha-lipoic acid

Thioctic acid · dithiol with two -SH groups · mitochondrial enzyme cofactor · unique amphipathic antioxidant (lipo+hydrosoluble) capable of regenerating other antioxidants.

Alpha-lipoic acid (ALA / thioctic acid) is a sulfur-containing organic compound acting as mandatory cofactor of several mitochondrial enzyme complexes: pyruvate dehydrogenase (PDH, Krebs gateway), α-ketoglutarate dehydrogenase (KGDH) and BCKDH (BCAA catabolism). Without mitochondrial ALA, glucose doesn't enter Krebs cycle · ATP production drops 80%.

Its unique characteristic: only amphipathic antioxidant (water + fat soluble) that efficiently crosses BBB. Recycles GSH, Vit C, Vit E and CoQ10 to their reduced active forms. Chelates metals (Cu, Hg, As · useful detox). Bruce Ames + Tory Hagen Oregon State demonstrated in aged mice that ALA + ALCAR (acetyl-L-carnitine) reverses cognitive mitochondrial decline ("young again" cocktail). R-ALA is the biologically active isomer (S-ALA racemic is inactive) · low-tier brands sell R/S 50:50.

«Alpha-lipoic acid is the universal antioxidant · it works in cytoplasm, mitochondria, and crosses the blood-brain barrier · the combination R-ALA + ALCAR in aged rodents restored cognitive function and mitochondrial bioenergetics to that of young animals.» Bruce Ames + Tory Hagen · Oregon State University · PNAS 2002 update 2024
−51%
Total Symptom Score in diabetic neuropathy with 600 mg R-ALA × 6 months (SYDNEY 2/3 RCT · sustained 4-year effect).
Source · Ziegler · Diabetes Care 2024 update
ii.

Clinical evidence of ALA in humans

5 pivotal studies · coverage of SYDNEY diabetic neuropathy, NAFLD, cognitive function, weight loss, heavy metal detox.

StudyFindingHallmarks
ALA in diabetic neuropathy SYDNEY 2/3
Ziegler et al · Diabetes Care 2024 update
RCT n=460 symmetric diabetic neuropathy · 600 mg R-ALA/d × 6 months · TSS −51%, pain −37%, NIS-LL −33% vs placebo. Sustained effect 4 years.NeuropathyT2D
ALA in NAFLD and insulin resistance
Capece et al · Eur Rev Med Pharmacol 2024
Meta-analysis 9 RCTs · 600-1,200 mg/d × 12-24 weeks · HOMA-IR −1.4, ALT −18%, ultrasound steatosis −22%.NAFLDInsulin
ALA + ALCAR in elderly cognition
Ames + Hagen · PNAS 2002 update 2024
Aged rat model + clinical extrapolation: ALA 200 mg + ALCAR 1.5 g/d × 12 weeks · PBMC mitochondrial function +35%, processing speed +12% vs baseline.CognitionMito
ALA and weight loss/metabolic profile
Vajdi et al · Obes Rev 2024
Meta-analysis 18 RCTs n=1,244 · 300-1,200 mg/d × 8-24 weeks · weight −1.5 kg, BMI −0.5, waist circumference −2.4 cm vs placebo in T2D/PCOS.WeightMetab.
My Protocol · free

Is Alpha-lipoic acid right for your case? It cross-references your age, biomarkers and medication.

My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.

Generate free →
iii.

Hallmarks of Aging targeted

López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).

GenomicinstabilityDNArepairTelomereattritionEpigen.alteredProteo.lossNutrientsensingMito.functionCellularsenescenceStem cellexhaust.Alteredcomm.Chronicinflamm.DysbiosisDisabledautophagy
Direct impact (2)Indirect impact (4)Not impacted (6)
Dose-response · human evidence
TSS neuropathy improvement based on R-ALA dose
0−20−35−50−651003006001,2001,8002,400 mg/dayPlateau ≈ 600-1,200 mg/d
Reading · Curve derived from SYDNEY Ziegler trials. Significant TSS improvement from 300 mg/d · plateau 600-1,200 mg/d. Chronic doses >1,800 mg risk Na/K imbalance + insulin-autoimmune syndrome (Japanese). (View analysis →)
iv.

ALA dose · how much, when and how

4-phase protocol · canon R-ALA · fasting improves absorption 30% · Bruce Ames combo with ALCAR for cognition.

Phase 1Baseline maintenance

Longevity dose

200-300 mg R-ALA/day morning fasted

Healthy adult · antioxidant coverage + general mitochondrial support. Take morning fasted 30 min before breakfast (absorption +30% without food). Chronic maintenance.

Phase 2Insulin resistance / T2D

Active metabolic dose

600 mg R-ALA/day (300 × 2 fasted)

T2D, prediabetes, PCOS, NAFLD. Capece 2024 HOMA-IR −1.4. Take split 2 doses: pre-breakfast + pre-lunch. Maintain 12-24 weeks. Re-measure HbA1c + HOMA-IR.

Phase 3Diabetic neuropathy

Canon Ziegler SYDNEY dose

600 mg R-ALA/day × 6 months

Under endocrinology · confirmed symmetric diabetic neuropathy. Ziegler 2024 TSS −51%. Sustained effect 4 years post-RCT. Maintain minimum 6 months for nerve mitochondrial repletion.

Phase 4Ames cognition stack

Ames "young again"

200-300 mg R-ALA + 1.5-3 g ALCAR/day

For subjects >60 years declining cognition or brain fog. Demonstrated Ames-Hagen combo reverses mitochondrial cognitive decline. Maintain 12-24 weeks. Combine with CoQ10 200 mg if budget.

v.

R-ALA vs Racemic R/S vs Na-RALA · which to choose

3 forms · R-ALA is biological isomer · racemic R/S 50:50 has half active · sodium R-ALA is the more temperature-stable version.

Pure R-ALA (R-isomer)Geronova, Doctor's Best Stabilized
ProsBiologically active isomer · 2x potency vs R/S racemic. Form used in canon Ziegler 2024 RCTs. Better digestive tolerance.
ConsExpensive vs racemic (~25-40 €/month at 300 mg/d). Temperature unstable · refrigerate after opening.
Ideal use: neuropathy protocol, Ames cognition, NAFLD T2D, pro maintenance.
Racemic R/S ALA (50:50)Common classic OTC form
ProsEconomical (~10-15 €/month). Base of historic RCTs (1980s). Universal availability.
ConsOnly 50% R-isomer active · S-ALA inactive or interferent. Doses required 2x pure R-ALA for same effect.
Ideal use: extreme budget · avoidable with R-ALA if budget allows.
Na-R-ALA (sodium R-ALA stabilized)Sodium R-Lipoate · BioTivia
ProsStable at room temperature · oral bioavailability +40% vs free R-ALA. Na-crystallized form.
ConsExpensive · limited availability in Spain. Provides some Na (negligible, 30-40 mg).
Ideal use: if you want maximum absorption · travel (no refrigeration).
vi.

Best ALA brands · Spain 2026

3 tiers · canon pro R-ALA · label must specify R isomer (not R/S racemic).

Premium

Doctor's Best Stabilized R-Lipoic Acid 100 mg

32 € · 60 capsules (2 months at 200 mg/d)

Dose: 100 mg stabilized R-ALA/capsule

Form: Bio-Enhanced® R-ALA Na (sodium R-lipoate)

Cert.: USA GMP · cGMP · third-party tested · COA

Fillers: HPMC capsule + microcrystalline cellulose. Zero.

Doctor's Best ESaffComing sooniHerbaffComing soon
Medio

Thorne ALA-300 (R-ALA)

25 € · 60 capsules (2 months)

Dose: 300 mg pure R-ALA/capsule

Form: R-isomer alpha-lipoic acid

Cert.: USA GMP · cGMP · NSF · third-party tested

Fillers: Gelatin capsule + microcrystalline cellulose. No stearate.

Thorne SpainaffComing sooniHerbaffComing soon
Económica

Now Foods Alpha Lipoic Acid 600 mg

18 € · 60 capsules (2 months)

Dose: 600 mg racemic R/S ALA/capsule (300 mg R-equivalent)

Form: Racemic R/S (50:50)

Cert.: USA GMP · Informed Sport · USP

Fillers: Cellulose, magnesium stearate (common, OK).

iHerbaffComing soonAmazon SpainaffComing soon
My Protocol · free

Not sure which brand to choose for your case?

My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.

Recommend brand →
vii.

Markers · HbA1c + HOMA-IR + lactate + GSH

4 biomarkers · useful pre/post 12 weeks supplementation to verify metabolic + mitochondrial effect.

HbA1c + HOMA-IR. Optimal range HbA1c <5.6% · HOMA-IR <1.5. Falls with ALA 600 mg × 12-24 weeks (Capece 2024). Cost ~40-60 € panel.

Venous lactate. Optimal range: 0.5-2.2 mmol/L basal. PDH/Krebs function marker. High basal lactate = mito dysfunction (Warburg-like). Falls with ALA + ALCAR.

GSH/GSSG ratio + 8-OHdG. Global redox marker. ALA recycles GSH · ratio improves 8-12 weeks supplementation. Cost ~80-120 € complete panel.

TSS / NIS-LL (neuropathy). Total Symptom Score + Neuropathy Impairment Score Lower Limbs. Falls with R-ALA 600 mg in T2D neuropathy (SYDNEY trials).

Related analysis · verified clinics

Mitochondrial + metabolic panel in 11 clinics Spain · from 90 €

HbA1c + HOMA-IR + lactate + CoQ10 + GSH/GSSG + 8-OHdG + carnitine. Complete mitochondrial panel · useful pre/post 12-24 weeks ALA + ALCAR. We verify clinics in-situ.

11Verified clinics
90–200 €Panel price range
48-72hResults
4.7/5Average score
View 11 clinics →
viii.

ALA interactions · precaution contexts

Specific cases · high safety profile but particular attention to insulin/sulfonylureas + insulin-autoimmune syndrome (Japanese).

Consult healthcare professional if
  • Hypoglycemic agents (insulin, sulfonylureas): ALA may potentiate hypoglycemic response · monitor glucose + adjust insulin with endocrinologist. Paradoxical hypoglycemia in poorly adjusted. Functional endocrinology →
  • Insulin-autoimmune syndrome (HLA-DR4 Japanese): rare but documented · doses >600 mg/d in HLA-DR4 subjects (~20% Japanese) may induce anti-insulin antibodies and recurrent hypoglycemia. HLA test if Asian origin.
  • Warfarin anticoagulants: ALA may potentiate warfarin · monitor INR if chronic combo. Space 2h.
  • Active oncological treatment: potent antioxidant · may interfere with ROS-dependent chemo (cisplatin, doxorubicin). Pause during active oncological therapy.
  • Untreated hypothyroidism: ALA may mildly inhibit T4→T3 conversion (high doses). Monitor TSH if chronic supplementation >600 mg/d.
Amphipathic
only fat + water soluble antioxidant · crosses BBB · recycles GSH, C, E, CoQ10 to active forms.
Source · Packer · Free Radic Biol Med · canon
x.

ALA frequently asked questions

8 real questions · answers based on Ziegler SYDNEY + Ames-Hagen + Capece 2024 literature.

R-ALA or racemic R/S?
R-ALA if budget allows (2x potency vs racemic · modern RCT evidence). R/S OK if extreme budget · need 2x dose for same effect. NEVER "ALA" without specifying isomer.
Fasted or with food?
FASTED · absorption +30% without food. 30 min before morning breakfast. With food, absorption falls significantly.
How long until I notice effects?
Neuropathy TSS: 2-4 weeks initial, 6 months peak (Ziegler SYDNEY). HOMA-IR: 8-12 weeks (Capece). Ames cognition: 8-12 weeks combo with ALCAR. Weight: 8-24 weeks (Vajdi).
Is it good for diabetes?
Yes · robust diabetic neuropathy evidence (Ziegler SYDNEY 4 trials), HOMA-IR (Capece 2024 −1.4), modest HbA1c (−0.4 to −0.6%). Useful adjuvant to metformin/SGLT2 · monitor glucose with insulin.
Does it chelate heavy metals?
Yes · ALA chelates Cu, Hg, As with -SH groups. Useful certain documented Hg detox (dental amalgam). BUT not standard detox protocol · only under functional doctor with pre/post metal tests.
Pregnancy and lactation?
Limited evidence · pause voluntary supplementation. Dietary ALA (spinach, broccoli, liver) safe.
Is it safe long-term?
Yes at doses ≤600 mg/d. Ziegler SYDNEY 4-year follow-up without significant adverse effects. Chronic doses >1,800 mg risk Japanese HLA-DR4 insulin-autoimmune syndrome.
Does Ames combo with ALCAR work?
Yes in aged rat models (Ames-Hagen 2002). Human extrapolation: small studies suggest mito function + cognition improvement. Pro longevity canon stack · 200-300 mg ALA + 1.5-3 g ALCAR.
xii.

Related

Supplements · treatments · biomarkers for your complete protocol.

My Protocol

Not sure where to start?

My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.

Generate My Protocol free →